October 28, 2025 · Form 4 insider transaction
Ragosa Mark sold 100 shares of Kiniksa Pharmaceuticals Ltd. at $41.00 per share, a transaction worth $4.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.